Search
for

    Sort by

    Research 871–900 of 1000+

    1. P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata British Journal of Dermatology · 2025
    2. BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib British Journal of Dermatology · 2025
    3. BH31 Dermoscopic analysis of patients with and without poor prognostic indicators in alopecia areata: a comparative study British Journal of Dermatology · 2025
    4. Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute The Journal of Dermatology · 2025
    5. Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study International Journal of Science and Research (IJSR) · 2025
    6. Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy Preprints.org · 2025
    7. Etrasimod for alopecia areata: The scenario for a less extensive and moderate form Journal of the European Academy of Dermatology and Venereology · 2025
    8. Alopecia areata and ritlecitinib: Unravelling response trajectories Journal of the European Academy of Dermatology and Venereology · 2025
    9. Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study Cureus · 2025
    10. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata Cureus · 2025
    11. Evaluation of the Efficacy of Antihistamines in the combined therapy for Alopecia Areata Russian Journal of Allergy · 2025
    12. Comparing the Efficacy of Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata Pakistan Journal of Health Sciences · 2025
    13. JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series International Journal of Dermatology · 2025
    14. Successful treatment of severe diffuse alopecia areata with abrocitinib Anais Brasileiros de Dermatologia · 2025
    15. Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cureus · 2025
    16. Ivarmacitinib stimulates hair regrowth in severe alopecia areata 2025
    17. Bempikibart shows its potential for hair regrowth in alopecia areata 2025
    18. Journal of Population Therapeutics and Clinical Pharmacology 2025
    19. Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report Frontiers in Immunology · 2025
    20. Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata Egyptian journal of Immunology · 2025
    21. Comparison of Trichoscopic Features of Alopecia Areata before and after Treatment with Intralesional Steroids Pakistan Journal of Health Sciences · 2025
    22. Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients Indian Journal of Dermatology Venereology and Leprology · 2025
    23. Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program SKIN The Journal of Cutaneous Medicine · 2025
    24. 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata 2025
    25. 5PSQ-117 Effectiveness of baricitinib in alopecia areata 2025
    26. Scarring Alopecia in a 66‐Year‐Old Woman JEADV Clinical Practice · 2025
    27. Alopecia Universalis: Never Give Up? PubMed · 2025
    28. Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center The Journal of Dermatology · 2025
    29. Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2025
    30. Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis Frontiers in Pediatrics · 2025